HCQ Treatment Improves Odds 3-5 times

The Dr. Zelenko’s paper reported a 5x decrease in deaths and hospitalizations among COVID-19 patients who were treated early with HCQ+AZ+Zn, compared with similar patients who did not receive this treatment. Note that Dr. Zelenko treated only high risk patients and did not wait for test results before prescribing treatment. (The tests were performed or completed later)

The Henry Ford Hospitals’  study reported a 3x decrease in deaths among hospitalized patients receiving  HCQ treatments, compared with the control group, after matching propensity scores. This is much more than the 2x improvement, usually quoted by the media:

Hydroxychloroquine provided a 66% hazard ratio reduction, and hydroxychloroquine + azithromycin 71% compared to neither treatment (p < 0.001)

FDA LIED — PEOPLE DIED

In its June 15 letter, the FDA revoked the Emergency Use Authorization for Hydroxychloroquine, without affecting the status of hydroxychloroquine as an approved drug. The letter claimed 347 reports of adverse effects associated with HCQ, implying all these cases were reported from the US, and referencing an unpublished review. It published the review only on July 1. The review  listed only 97 cases reported in the US. There were also 250 cases abroad. 347 was a number of reported cases worldwide, not in the US.

Early HCQ plus AZ Treatment can End COVID-19 Epidemic

2020-07-10: A long letter HCQ vs C19 is uploaded, then updated on 07-11.

To stop COVID-19, treat patients early with HCQ + AZ. That rapidly decreases the viral load in patients and thus, their probability of infecting others.

When the R drops below 1, the epidemic ends. Countries using CQ/HCQ for malaria, including India, Indonesia, Malaysia, and African countries, did not have a COVID-19 epidemic. Countries who started using HCQ+AZ in the early stage of the disease, stopped the epidemic.  All countries with high mortality rates did not use HCQ (except for Belgium, who used it too little and too late).

Peer reviewed studies show that Hydroxychloroquine works: “Global HCQ studies. PrEP, PEP, and early treatment studies show high effectiveness, while late treatment shows mixed results.

Originally published on July 6. Updated on July 10.

Peonage Was Abolished. Do Twitter, Facebook, and YouTube Know?

Twitter, Google’s YouTube, and Facebook use the uncompensated labor of their users. These platforms sell that labor, as a media product, to other users and advertisers for tens of billions of dollars.

Granted, not every tweet is labor, and not every Facebook or Twitter user is a laborer. But people who contribute using their professional skills or in a work-like manner (for example citizen-journalists or scientists) are indeed laborers. A single post or tweet might express the results of weeks or months of investigative journalism or research.

Twitter started as a communication utility. YouTube marketed itself as a platform for self-expression. Facebook was something of both. However, things started to change as all three companies introduced significant requirements for user-produced content. Slowly, the requirements became stricter and longer, becoming almost product specifications for the content. Only YouTube financially compensates its user-contributors, but considers this a privilege, to be granted or withdrawn at will (“demonetization”). Continue reading Peonage Was Abolished. Do Twitter, Facebook, and YouTube Know?

Trump – Putin Collusion in COVID19

🙂 New evidence of Trump – Putin collusion! Trump and Putin both encouraged the use of hydroxychloroquine for COVID-19 treatment and prevention, despite the lack of evidence of its efficacy (not counting in-vitro research, clinical success in France, South Korea, China, and some 3-4 randomized controlled trials). Russia and the “Trump country” states report less than 100 COVID-19 deaths per million population. Russia has embraced hydroxychloroquine-based treatment for COVID-19.  Continue reading Trump – Putin Collusion in COVID19

HCQ is Very Effective for COVID19, Doctors Say

On May 22-24, Sermo surveyed more than 4,000 physicians globally, 555 of whom treated COVID-19 patients. The results:

  • Hydroxychloroquine-based treatment remain the first choice of doctors for outpatient treatment globally, with a few exceptions such as the US, UK, Canada.
  • No treatment is the first choice of doctors in the US and UK; HCQ-based treatments are the second choice
  • 35% of doctors using it said that Hydroxychloroquine is Extremely Effective or Very Effective in treating COVID-19 (excluding ‘no opinion’ answer)

Only 14% of US doctors treated outpatients with HCQ, compared with 30% abroad. “AZM or similar” was used by only 26% of US doctors compared with 49% abroad. It was even worse in the UK and Canada. Continue reading HCQ is Very Effective for COVID19, Doctors Say